通过空间转录组学,单细胞分析和副本数变异解读卵巢癌异质性
Songyun Li1,2, Zhuo Wang1,2, Hsien-Da Huang1,2
1Warshel Institute for Computational Biology, The Chinese University of Hong Kong, Shenzhen, Guangdong, P.R. China.
PloS one
|March 4, 2025
概括
高度血清性卵巢癌 (HGSOC) 是由于多药性耐药性而具有挑战性的. 这项研究揭示了瘤异质性的驱动因素,并确定MDK-NCL相互作用是HGSOC生长的关键目标,提供了新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 细胞生物学 细胞生物学
背景情况:
- 高度血清性卵巢癌 (HGSOC) 带来了重大的临床挑战,主要是由于瘤异质性引起的多药性耐药性 (MDR).
- 了解推动HGSOC异质性的复杂机制对于开发有效的治疗策略至关重要.
研究的目的:
- 在基因表达,拷贝数变异 (CNV) 和单细胞概况等级全面分析HGSOC异质性.
- 确定关键的细胞相互作用和分子驱动因素,有助于HGSOC瘤生长和抵抗.
主要方法:
- 来自8名HGSOC患者的5个单细胞转录组和8个空间转录组的综合分析.
- 复制数变异 (CNV) 分析以识别瘤克隆及其进化轨迹.
- 单细胞RNA测序 (scRNA seq) 用于定义细胞元程序和通信网络.
主要成果:
- CNV分析揭示了具有不同进化路径和空间分布的独特瘤克隆,突出显示了瘤内部异质性.
- scRNA seq 在瘤细胞中发现了三个功能性元程序,每个与不同的通信网络相关.
- MDK-NCL连接体-受体对被确定为促进瘤细胞增殖的关键相互作用,由NCL过度表达实验证实.
结论:
- HGSOC异质性是多方面的,涉及不同的瘤克隆和复杂的细胞通信网络.
- MDK-NCL相互作用是HGSOC瘤生长的重要驱动因素,并代表了一个潜在的治疗标.
- 这项研究提供了对HGSOC异质性的见解,并提出了对抗这种恶性瘤的新策略.
相关概念视频
02:26Comparing Copy Number Variations and SNPs
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...